Concepedia
Statistics
Publications
23
Citations
2K
H-Index
20
Active since
1986
Affiliations
United States Food and Drug Administration(Current)
Center for Drug Evaluation and Research
National Cancer Institute
United States Department of Health and Human Services
University of Massachusetts Chan Medical School
V. Ellen Maher is an author at United States Food and Drug Administration specializing in medicine, oncology, and cancer research.
Top concepts
MedicineOncologyCancer ResearchClinical TrialsPharmacotherapyImmunologyPharmacologyImmunotherapyCancer TherapyRadiation Oncology
Publications per year
1986–2019
Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody
V. Ellen Maher, Laura L. Fernandes, Chana Weinstock et al. · Journal of Clinical Oncology · 2019 · 336 citations
FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin-Containing Chemotherapy
Daniel L. Suzman, Sundeep Agrawal, Yang-Min Ning et al. · The Oncologist · 2018 · 199 citations · Full text
Immunization With Mutant<i>p53</i>- and<i>K-ras</i>–Derived Peptides in Cancer Patients: Immune Response and Clinical Outcome
David P. Carbone, I. Frank Ciernik, Michael J. Kelley et al. · Journal of Clinical Oncology · 2005 · 169 citations · Full text
Radium Ra 223 Dichloride Injection: U.S. Food and Drug Administration Drug Approval Summary
Paul G. Kluetz, William F. Pierce, V. Ellen Maher et al. · Clinical Cancer Research · 2013 · 162 citations
Dichloride Injection, Cancer Management, Pharmacotherapy +17
FDA Approval Summary: Nivolumab in Advanced Renal Cell Carcinoma After Anti-Angiogenic Therapy and Exploratory Predictive Biomarker Analysis
James Xu, V. Ellen Maher, Lijun Zhang et al. · The Oncologist · 2017 · 149 citations · Full text
1–5 of 23